Citation Impact
Citing Papers
EGFR Antagonists in Cancer Treatment
2008 Standout
Beneficial Therapeutic Effect of Plasmapheresis After Unsuccessful Treatment With Corticosteroids in Two Patients With Severe Toxic Epidermal Necrolysis
2010
Novel interferon-γ enzyme-linked immunoSpot assay using activated cells for identifying hypersensitivity-inducing drug culprits
2017 StandoutNobel
Safety evaluation of topical applications of ethanol on the skin and inside the oral cavity
2008 Standout
Ulcerative Colitis Practice Guidelines in Adults (Update): American College of Gastroenterology, Practice Parameters Committee
2004 Standout
Crohn's disease
2012 Standout
Toxic epidermal necrolysis: Review of pathogenesis and management
2011
TFOS DEWS II pathophysiology report
2017 Standout
Transdermal resorption of an ethanol- and 2-propanol-containing skin disinfectant
2007
Placement of ProKera in the Management of Ocular Manifestations of Acute Stevens-Johnson Syndrome in an Outpatient
2012
Toxic epidermal necrolysis (Lyell's disease)
2009
The Genetics of Pemphigus
2011
The risk of herpes zoster in patients with rheumatoid arthritis in the United States and the United Kingdom
2007
Frequency, phenotype, outcome, and therapeutic impact of skin reactions following initiation of adalimumab therapy: Experience from a consecutive cohort of inflammatory bowel disease patients
2011
Pemphigus: Etiology, pathogenesis, and inducing or triggering factors: Facts and controversies
2013 Standout
Targeting the Raf-MEK-ERK mitogen-activated protein kinase cascade for the treatment of cancer
2007 Standout
Toxic epidermal necrolysis
2013
TFOS DEWS II Management and Therapy Report
2017 Standout
Mechanisms of cutaneous toxicities to EGFR inhibitors
2006
Herpes zoster in patients taking TNFα antagonists for chronic inflammatory joint disease
2008
The impact of treatment with tumour necrosis factor-α antagonists on the course of chronic viral infections: a review of the literature
2008
Amniotic Membrane Transplantation as a New Therapy for the Acute Ocular Manifestations of Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis
2009
Review article: chronic viral infection in the anti‐tumour necrosis factor therapy era in inflammatory bowel disease
2009
The predominant drug-specific T-cell population may switch from cytotoxic T cells to regulatory T cells during the course of anticonvulsant-induced hypersensitivity
2011
Guidelines on the Use of Therapeutic Apheresis in Clinical Practice – Evidence‐Based Approach from the Writing Committee of the American Society for Apheresis: The Eighth Special Issue
2019 Standout
European S1 guideline for the treatment of hidradenitis suppurativa/acne inversa
2015 Standout
Supportive Therapy for a Patient With Toxic Epidermal Necrolysis Undergoing Plasmapheresis
2013
Prevention of herpes zoster: recommendations of the Advisory Committee on Immunization Practices (ACIP).
2008 Standout
Granulysin is a key mediator for disseminated keratinocyte death in Stevens-Johnson syndrome and toxic epidermal necrolysis
2008
2013 IDSA Clinical Practice Guideline for Vaccination of the Immunocompromised Host
2013 Standout
Review of Toxic Epidermal Necrolysis
2016
A comprehensive review and evaluation of the side effects of the tumor necrosis factor alpha blockers etanercept, infliximab and adalimumab
2004
Works of N.J. Mortimer being referenced
Evidence of an association between desmoglein 3 haplotypes and pemphigus vulgaris
2005
Acute generalized exanthematous pustulosis associated with azathioprine hypersensitivity
2006
Toxic epidermal necrolysis: current evidence, practical management and future directions
2005
Acute neuropathy and erythromelalgia following topical exposure to isopropanol.
2004
Severe herpes zoster after infliximab infusion
2004